Jundong Zhou

2.3k total citations
78 papers, 1.9k citations indexed

About

Jundong Zhou is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jundong Zhou has authored 78 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 25 papers in Oncology and 25 papers in Cancer Research. Recurrent topics in Jundong Zhou's work include RNA modifications and cancer (11 papers), MicroRNA in disease regulation (10 papers) and Genetic factors in colorectal cancer (9 papers). Jundong Zhou is often cited by papers focused on RNA modifications and cancer (11 papers), MicroRNA in disease regulation (10 papers) and Genetic factors in colorectal cancer (9 papers). Jundong Zhou collaborates with scholars based in China, United States and France. Jundong Zhou's co-authors include Jinchang Wu, Shuyu Zhang, Jianping Cao, Wei-Qun Ding, Shitao Zou, Yimin Zhu, Chao He, Yaqing Jin, Fang Xie and Wei‐Qun Ding and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Jundong Zhou

78 papers receiving 1.8k citations

Peers

Jundong Zhou

ONCOL

PRM

IMMUN

Chunlin Ou China

Kai Li China

Mihai Gagea United States

Jong Kook Park South Korea

Jan Bouchal Czechia

Caiping Ren China

Huiyan Sun China

Hao Wen China

Jinguan Lin China

Chunlin Ou China

Jundong Zhou

1.3k ×1.1

897 ×1.3

340 ×0.9

ONCOL

224 ×1.0

PRM

266 ×1.4

IMMUN

Citations per year, relative to Jundong Zhou Jundong Zhou (= 1×) peers Chunlin Ou

Countries citing papers authored by Jundong Zhou

Since Specialization

Citations

This map shows the geographic impact of Jundong Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jundong Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jundong Zhou more than expected).

Fields of papers citing papers by Jundong Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jundong Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jundong Zhou. The network helps show where Jundong Zhou may publish in the future.

Co-authorship network of co-authors of Jundong Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Jundong Zhou. A scholar is included among the top collaborators of Jundong Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jundong Zhou. Jundong Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Fengyuan, et al.. (2025). Regulation and mechanism of Bletilla striata polysaccharide on delaying aging in Drosophila melanogaster. International Journal of Biological Macromolecules. 310(Pt 3). 143382–143382. 5 indexed citations

Xue, Yujie, et al.. (2024). Network Pharmacology and Molecular Docking Study on the Mechanism of the Therapeutic Effect of Strychni Semen in NSCLC. Biological Procedures Online. 26(1). 33–33. 3 indexed citations

Yuan, Jingping, Jundong Zhou, Liangfang Shen, et al.. (2024). 1526P Anti-PD-L1/TGF-βRII fusion protein SHR-1701 combined with nab-paclitaxel and gemcitabine in previously untreated patients with locally advanced or metastatic pancreatic cancer: A multicenter, phase Ib/II study. Annals of Oncology. 35. S931–S932. 1 indexed citations

Zou, Shitao, Jing Xu, Chao He, et al.. (2022). RAD18 confers radioresistance of esophagus squamous cell carcinoma through regulating p‐DNA‐PKcs. Cancer Medicine. 11(20). 3809–3819. 9 indexed citations

Zhang, Yan, Chuanfeng Wu, Guoping Shan, et al.. (2022). Setup error assessment based on “Sphere-Mask” Optical Positioning System: Results from a multicenter study. Frontiers in Oncology. 12. 918296–918296. 1 indexed citations

Li, Xiaoqing, Shitao Zou, Chao He, et al.. (2021). DNA Polymerase Iota Promotes Esophageal Squamous Cell Carcinoma Proliferation Through Erk-OGT-Induced G6PD Overactivation. Frontiers in Oncology. 11. 706337–706337. 16 indexed citations

Lin, Li, et al.. (2018). MiR-2861 Behaves as a Biomarker of Lung Cancer Stem Cells and Regulates the HDAC5-ERK System Genes. Cellular Reprogramming. 20(2). 99–106. 16 indexed citations

Xia, Xiaochun, Chao He, Anqing Wu, Jundong Zhou, & Jinchang Wu. (2018). Microtubule-Associated Protein 4 Is a Prognostic Factor and Promotes Tumor Progression in Lung Adenocarcinoma. Disease Markers. 2018. 1–8. 17 indexed citations

Li, Chunlin, Jundong Zhou, Chen Ding, et al.. (2017). Peptide Blocking of PD-1/PD-L1 Interaction for Cancer Immunotherapy. Cancer Immunology Research. 6(2). 178–188. 140 indexed citations

10.

Ge, Yugang, Yu He, Dakui Luo, et al.. (2017). Polymorphisms in lncRNA PTENP1 and the Risk of Gastric Cancer in a Chinese Population. Disease Markers. 2017. 1–8. 19 indexed citations

11.

Li, Ming, Shanhu Li, Biao Liu, et al.. (2017). PIG3 promotes NSCLC cell mitotic progression and is associated with poor prognosis of NSCLC patients. Journal of Experimental & Clinical Cancer Research. 36(1). 39–39. 18 indexed citations

12.

Xue, Jiao, Chenxiao Yu, Wei Zhu, et al.. (2017). The Nrf2/GCH1/BH4 Axis Ameliorates Radiation-Induced Skin Injury by Modulating the ROS Cascade. Journal of Investigative Dermatology. 137(10). 2059–2068. 81 indexed citations

13.

Yang, Ru, Weipei Zhu, Jundong Zhou, et al.. (2016). Adenovirus-mediated truncated Bid overexpression induced by the Cre/LoxP system promotes the cell apoptosis of CD133+ ovarian cancer stem cells. Oncology Reports. 37(1). 155–162. 16 indexed citations

14.

Wang, Wenjie, Chenxiao Yu, Jianping Cao, et al.. (2015). REV3L modulates cisplatin sensitivity of non-small cell lung cancer H1299 cells. Oncology Reports. 34(3). 1460–1468. 27 indexed citations

15.

Zhou, Jundong, Bing Zheng, Jiansong Ji, et al.. (2014). LYTAK1, a novel TAK1 inhibitor, suppresses KRAS mutant colorectal cancer cell growth in vitro and in vivo. Tumor Biology. 36(5). 3301–3308. 13 indexed citations

16.

Xu, Min, Zhirong Chen, Jundong Zhou, et al.. (2014). Bortezomib induces protective autophagy through AMP-activated protein kinase activation in cultured pancreatic and colorectal cancer cells. Cancer Chemotherapy and Pharmacology. 74(1). 167–176. 50 indexed citations

17.

Wang, Shuai, Bethany N. Hannafon, Jundong Zhou, & Wei-Qun Ding. (2013). Clofibrate Induces Heme Oxygenase 1 Expression through a PPARa-Independent Mechanism in Human Cancer Cells. Cellular Physiology and Biochemistry. 32(5). 1255–1264. 14 indexed citations

18.

Zhang, Shuyu, Chuanjun Song, Jundong Zhou, et al.. (2012). Amelioration of radiation-induced skin injury by adenovirus-mediated heme oxygenase-1 (HO-1) overexpression in rats. Radiation Oncology. 7(1). 4–4. 26 indexed citations

19.

Zhou, Jundong, Shuyu Zhang, Ling Xie, et al.. (2012). Overexpression of DNA polymerase iota (Polι) in esophageal squamous cell carcinoma. Cancer Science. 103(8). 1574–1579. 38 indexed citations

20.

Zhang, Shuyu, Jun Hao, Fang Xie, et al.. (2011). Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development. Carcinogenesis. 32(8). 1183–1189. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact